NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma
Andrea M. Griesinger(Morgan Adams Foundation), Nicholas K. Foreman(Children's Hospital Colorado), Sydney Grob(Morgan Adams Foundation), Bridget Sanford(University of Colorado Denver), Ilango Balakrishnan(Morgan Adams Foundation), Michael H. Handler(Children's Hospital Colorado), Sujatha Venkataraman(Children's Hospital Colorado), John DeSisto(Morgan Adams Foundation), Davis Witt(Morgan Adams Foundation), Andrew M. Donson(Children's Hospital Colorado), Sabrina R Georgio Westover(Morgan Adams Foundation), Lindsey M. Hoffman(St Nicholas Hospital), Jean M. Mulcahy Levy, Kenneth L. Jones(University of Colorado Denver), Daniel C. Moreira(St. Jude Children's Research Hospital), Randall Wong(Morgan Adams Foundation), Rajeev Vibhakar(University of Colorado Denver)
Cited by 23
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|654
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
|Journal of Clinical Oncology|2018|433
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345